Funding
i4L Innogrant for Biotherapeutics · Healthtech

NourishAI wins CHF100,000 i4L Innogrant

EPFL backs development of a clinician nutrition decision tool for ALS.

By RoundOS Funding desk

NourishAI was awarded a CHF100,000 i4L Innogrant for Biotherapeutics, EPFL announced on March 26, 2026. The team will validate computational findings against clinical data and build a clinician decision-tool prototype.

The project combines genetic, metabolic and clinical information to investigate individual nutrition needs in ALS.

Use of funds

Validate clinical data and prototype a clinician nutrition decision tool.

Funding history

i4L Innogrant for Biotherapeutics · This roundCHF 100K
Future of Health Grant Level 1UndisclosedEPFL Ignition grantCHF 30K

Sources

  1. EPFL startup grant award announcementactu.epfl.ch · Mar 26, 2026

Similar rounds

All Healthtech rounds →
LIFESCAPES

Japanese developer of brain-machine interface rehabilitation devices for people with impaired hand movement.

UndisclosedFollow-on equity investment · Oct 30, 2026
Jagruti Rehabilitation Centre

Jagruti Rehabilitation Centre operates residential facilities for mental healthcare, addiction treatment and dementia care across India.

₹280MSeries A · Oct 29, 2026
Docterz

Docterz provides clinic software for patient records, appointments, billing, vaccination management and communication between doctors and patients.

₹50MUndisclosed · Oct 29, 2026
Magic Vision

Magic Vision develops AI monitoring technology that helps care providers and families respond to falls and changes in daily activity.

€600KFunding round · Oct 28, 2026

Related